MedTrace Logo

Prostate Cancer Screening Trial Using Imaging

NCT03702439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 411

Last updated 2022-01-27

Study results available
· View outcomes & findings →

Summary

Participants will be recruited from the community and attend a screening clinic and undergo the following screening tests:

1. Bi-parametric MRI - reported by a radiologist and CAD-AI system
2. Multiparametric ultrasound - including shearwave elastography
3. A standard-of-care PSA test

A systematic +/- targeted biopsy will be performed if any tests are positive, independent of the other tests.

Conditions

  • Prostate Neoplasm

Sponsors & Collaborators

  • Imperial College Healthcare NHS Trust

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • AHMED HASHIM, Prof · Imperial College London

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2019-05-15
Completion
2019-08-22

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03702439 on ClinicalTrials.gov